| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |